HBK INVESTMENTS L P - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 154 filers reported holding WUXI PHARMATECH CAYMAN INC in Q2 2014. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.

Quarter-by-quarter ownership
HBK INVESTMENTS L P ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q4 2014$520,000
-54.4%
15,431
-52.6%
0.01%
-66.7%
Q3 2014$1,140,000
+34.8%
32,563
+26.5%
0.02%
+5.9%
Q2 2014$846,000
-10.3%
25,741
+4.7%
0.02%
-5.6%
Q4 2013$943,000
-26.1%
24,574
-47.2%
0.02%
-5.3%
Q3 2013$1,276,000
+4.6%
46,566
-19.9%
0.02%0.0%
Q2 2013$1,220,00058,1000.02%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q2 2014
NameSharesValueWeighting ↓
PSquared Asset Management AG 171,495$7,410,00032.67%
Newport Asia LLC 714,600$30,877,00012.95%
Coupland Cardiff Asset Management LLP 45,000$1,944,0006.29%
NINE MASTS CAPITAL Ltd 525,985$22,730,0005.83%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 2,694,589$116,433,0005.17%
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC 220,131$9,512,0004.79%
Sensato Investors LLC 549,341$23,737,0004.44%
Grandeur Peak Global Advisors, LLC 396,743$17,143,0003.83%
Taconic Capital Advisors LP 2,150,000$92,902,0003.43%
Central Asset Investments & Management Holdings (HK) Ltd 68,815$2,973,0003.26%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders